Pan-cancer analysis identifies CLEC12A as a potential biomarker and therapeutic target for lung adenocarcinoma

Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s12935-025-03755-5. Article type: Research Article Keywords: CLEC12A, Pan-cancer, Biomarker, Immune, LUAD, Therapy Authors: Desheng Zhou, Yachao Cui, Tianxiang Liang, Zhenpeng Wu, Haiping Yan, Yingchang Li, Wenguang Yin, Yunen Lin, Qiang You ⚬ Affiliations: https://ror.org/00zat6v61grid.410737.60000 0000 8653 1072Guangzhou Institute of Cancer Research, The Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, China; https://ror.org/00z0j0d77grid.470124.4State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The